CA Stock MarketDetailed Quotes

MDP Medexus Pharmaceuticals Inc

Watchlist
  • 1.620
  • -0.010-0.61%
15min DelayMarket Closed May 31 16:00 ET
39.62MMarket Cap4.22P/E (TTM)

Medexus Pharmaceuticals Inc Key Stats

Earnings

Revenue Breakdown

Financial Indicators

Income Statement

Balance Sheet

Cash Flow

Quarterly+Annual
YOY yoy
Hide blank lines yoy
(Q3)Dec 31, 2023
(Q2)Sep 30, 2023
(Q1)Jun 30, 2023
(FY)Mar 31, 2023
(Q4)Mar 31, 2023
(Q3)Dec 31, 2022
(Q2)Sep 30, 2022
(Q1)Jun 30, 2022
(FY)Mar 31, 2022
(Q4)Mar 31, 2022
Total revenue
-12.25%25.21M
9.54%30.33M
36.92%31.56M
40.93%108.1M
41.31%28.63M
35.08%28.73M
54.66%27.69M
33.47%23.05M
-3.71%76.7M
14.88%20.26M
Operating revenue
-12.25%25.21M
9.54%30.33M
36.92%31.56M
40.93%108.1M
41.31%28.63M
35.08%28.73M
54.66%27.69M
33.47%23.05M
-3.71%76.7M
14.88%20.26M
Cost of revenue
-2.19%12.52M
21.71%14.05M
41.72%14.32M
23.94%48.06M
34.16%13.62M
31.01%12.8M
35.58%11.54M
-2.33%10.1M
2.97%38.77M
14.99%10.15M
Gross profit
-20.34%12.69M
0.83%16.28M
33.17%17.24M
58.30%60.04M
48.48%15.02M
38.54%15.93M
71.96%16.14M
86.94%12.94M
-9.71%37.93M
14.76%10.11M
Operating expense
-12.13%11.13M
-7.90%12.72M
-3.76%12.4M
2.48%51.55M
12.71%12.19M
7.23%12.66M
1.62%13.82M
-8.54%12.88M
21.88%50.3M
-12.78%10.82M
Selling and administrative expenses
-11.95%9.12M
-8.67%10.29M
-2.85%10.39M
9.24%42.16M
20.84%9.85M
10.41%10.35M
8.16%11.26M
0.40%10.7M
22.80%38.6M
-9.00%8.15M
-Selling and marketing expense
1.52%2.61M
-3.74%2.91M
-6.62%2.93M
19.78%11.39M
50.28%2.65M
25.48%2.57M
28.40%3.03M
-5.93%3.14M
1.14%9.51M
-37.18%1.77M
-General and administrative expense
-16.40%6.51M
-10.48%7.37M
-1.28%7.46M
5.80%30.77M
12.70%7.2M
6.20%7.78M
2.25%8.24M
3.30%7.55M
32.05%29.09M
3.89%6.39M
Research and development costs
-12.17%1.95M
-3.63%2.37M
-6.75%1.95M
-20.13%9.03M
-11.78%2.27M
-5.09%2.22M
-20.73%2.46M
-36.72%2.09M
21.11%11.31M
-22.25%2.57M
Depreciation amortization depletion
-32.22%61K
-26.53%72K
-40.21%58K
-11.31%353K
-23.60%68K
-3.23%90K
13.95%98K
-25.38%97K
-21.34%398K
-32.58%89K
-Depreciation and amortization
-32.22%61K
-26.53%72K
-40.21%58K
-11.31%353K
-23.60%68K
-3.23%90K
13.95%98K
-25.38%97K
-21.34%398K
-32.58%89K
Operating profit
-52.08%1.57M
52.60%3.55M
7,834.43%4.84M
168.59%8.49M
503.28%2.83M
1,169.28%3.27M
155.36%2.33M
100.85%61K
-1,793.02%-12.38M
80.46%-701K
Net non-operating interest income (expenses)
25.23%-2.66M
-28.42%-4.23M
-35.12%-4.26M
-11.31%-13.61M
-16.25%-3.61M
-12.41%-3.55M
-7.19%-3.29M
-9.19%-3.15M
-24.52%-12.22M
-21.99%-3.11M
Non-operating interest expense
-25.23%2.66M
28.42%4.23M
35.12%4.26M
11.31%13.61M
16.25%3.61M
12.41%3.55M
7.19%3.29M
9.19%3.15M
24.52%12.22M
21.99%3.11M
Other net income (expenses)
143.09%293K
81.10%-298K
-80.53%299K
-99.63%76K
300.50%797K
-130.60%-680K
-110.58%-1.58M
-55.59%1.54M
192.70%20.78M
102.50%199K
Gain on sale of security
195.13%293K
75.06%-298K
-80.88%299K
-95.97%844K
272.47%783K
-113.66%-308K
-107.62%-1.2M
-54.78%1.56M
212.31%20.94M
91.45%-454K
Special income (charges)
--0
--0
--0
-368.29%-768K
-97.86%14K
-1,027.27%-372K
51.28%-382K
---28K
95.65%-164K
124.73%653K
-Less:Restructuring and mergern&acquisition
--0
--0
--0
148.42%768K
99.42%-14K
1,027.27%372K
-51.28%382K
--28K
-142.08%-1.59M
-190.99%-2.4M
-Less:Impairment of capital assets
----
----
----
--0
----
----
----
----
--1.75M
----
Income before tax
17.19%-795K
61.71%-973K
156.96%884K
-31.96%-5.04M
100.33%12K
22.83%-960K
-133.35%-2.54M
76.44%-1.55M
87.87%-3.82M
74.38%-3.61M
Income tax
-147.71%-261K
-36.51%120K
251.30%233K
-565.46%-6.26M
-507.87%-6.84M
681.91%547K
107.49%189K
-154K
70.93%-941K
146.68%1.68M
Earnings from equity interest net of tax
Net income
64.57%-534K
59.96%-1.09M
146.57%651K
142.41%1.22M
229.68%6.86M
-31.04%-1.51M
-126.91%-2.73M
78.78%-1.4M
89.81%-2.88M
49.60%-5.29M
Net income continuous operations
64.57%-534K
59.96%-1.09M
146.57%651K
142.41%1.22M
229.68%6.86M
-31.04%-1.51M
-126.91%-2.73M
78.78%-1.4M
89.81%-2.88M
49.60%-5.29M
Noncontrolling interests
Net income attributable to the company
64.57%-534K
59.96%-1.09M
146.57%651K
142.41%1.22M
229.68%6.86M
-31.04%-1.51M
-126.91%-2.73M
78.78%-1.4M
89.81%-2.88M
49.60%-5.29M
Preferred stock dividends
Other under preferred stock dividend
Net income attributable to common stockholders
64.57%-534K
59.96%-1.09M
146.57%651K
142.41%1.22M
229.68%6.86M
-31.04%-1.51M
-126.91%-2.73M
78.78%-1.4M
89.81%-2.88M
49.60%-5.29M
Diluted earnings per share
71.43%-0.02
64.29%-0.05
142.86%0.03
140.00%0.06
225.93%0.34
0.00%-0.07
-126.42%-0.14
79.41%-0.07
91.94%-0.15
57.14%-0.27
Basic earnings per share
71.43%-0.02
64.29%-0.05
142.86%0.03
140.00%0.06
225.93%0.34
0.00%-0.07
-126.92%-0.14
79.41%-0.07
91.94%-0.15
57.14%-0.27
Dividend per share
Accounting Standards
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
Audit Opinions
--
--
--
Unqualified Opinion
--
--
--
--
Unqualified Opinion with Explanatory Notes
--
(Q3)Dec 31, 2023(Q2)Sep 30, 2023(Q1)Jun 30, 2023(FY)Mar 31, 2023(Q4)Mar 31, 2023(Q3)Dec 31, 2022(Q2)Sep 30, 2022(Q1)Jun 30, 2022(FY)Mar 31, 2022(Q4)Mar 31, 2022
Total revenue -12.25%25.21M9.54%30.33M36.92%31.56M40.93%108.1M41.31%28.63M35.08%28.73M54.66%27.69M33.47%23.05M-3.71%76.7M14.88%20.26M
Operating revenue -12.25%25.21M9.54%30.33M36.92%31.56M40.93%108.1M41.31%28.63M35.08%28.73M54.66%27.69M33.47%23.05M-3.71%76.7M14.88%20.26M
Cost of revenue -2.19%12.52M21.71%14.05M41.72%14.32M23.94%48.06M34.16%13.62M31.01%12.8M35.58%11.54M-2.33%10.1M2.97%38.77M14.99%10.15M
Gross profit -20.34%12.69M0.83%16.28M33.17%17.24M58.30%60.04M48.48%15.02M38.54%15.93M71.96%16.14M86.94%12.94M-9.71%37.93M14.76%10.11M
Operating expense -12.13%11.13M-7.90%12.72M-3.76%12.4M2.48%51.55M12.71%12.19M7.23%12.66M1.62%13.82M-8.54%12.88M21.88%50.3M-12.78%10.82M
Selling and administrative expenses -11.95%9.12M-8.67%10.29M-2.85%10.39M9.24%42.16M20.84%9.85M10.41%10.35M8.16%11.26M0.40%10.7M22.80%38.6M-9.00%8.15M
-Selling and marketing expense 1.52%2.61M-3.74%2.91M-6.62%2.93M19.78%11.39M50.28%2.65M25.48%2.57M28.40%3.03M-5.93%3.14M1.14%9.51M-37.18%1.77M
-General and administrative expense -16.40%6.51M-10.48%7.37M-1.28%7.46M5.80%30.77M12.70%7.2M6.20%7.78M2.25%8.24M3.30%7.55M32.05%29.09M3.89%6.39M
Research and development costs -12.17%1.95M-3.63%2.37M-6.75%1.95M-20.13%9.03M-11.78%2.27M-5.09%2.22M-20.73%2.46M-36.72%2.09M21.11%11.31M-22.25%2.57M
Depreciation amortization depletion -32.22%61K-26.53%72K-40.21%58K-11.31%353K-23.60%68K-3.23%90K13.95%98K-25.38%97K-21.34%398K-32.58%89K
-Depreciation and amortization -32.22%61K-26.53%72K-40.21%58K-11.31%353K-23.60%68K-3.23%90K13.95%98K-25.38%97K-21.34%398K-32.58%89K
Operating profit -52.08%1.57M52.60%3.55M7,834.43%4.84M168.59%8.49M503.28%2.83M1,169.28%3.27M155.36%2.33M100.85%61K-1,793.02%-12.38M80.46%-701K
Net non-operating interest income (expenses) 25.23%-2.66M-28.42%-4.23M-35.12%-4.26M-11.31%-13.61M-16.25%-3.61M-12.41%-3.55M-7.19%-3.29M-9.19%-3.15M-24.52%-12.22M-21.99%-3.11M
Non-operating interest expense -25.23%2.66M28.42%4.23M35.12%4.26M11.31%13.61M16.25%3.61M12.41%3.55M7.19%3.29M9.19%3.15M24.52%12.22M21.99%3.11M
Other net income (expenses) 143.09%293K81.10%-298K-80.53%299K-99.63%76K300.50%797K-130.60%-680K-110.58%-1.58M-55.59%1.54M192.70%20.78M102.50%199K
Gain on sale of security 195.13%293K75.06%-298K-80.88%299K-95.97%844K272.47%783K-113.66%-308K-107.62%-1.2M-54.78%1.56M212.31%20.94M91.45%-454K
Special income (charges) --0--0--0-368.29%-768K-97.86%14K-1,027.27%-372K51.28%-382K---28K95.65%-164K124.73%653K
-Less:Restructuring and mergern&acquisition --0--0--0148.42%768K99.42%-14K1,027.27%372K-51.28%382K--28K-142.08%-1.59M-190.99%-2.4M
-Less:Impairment of capital assets --------------0------------------1.75M----
Income before tax 17.19%-795K61.71%-973K156.96%884K-31.96%-5.04M100.33%12K22.83%-960K-133.35%-2.54M76.44%-1.55M87.87%-3.82M74.38%-3.61M
Income tax -147.71%-261K-36.51%120K251.30%233K-565.46%-6.26M-507.87%-6.84M681.91%547K107.49%189K-154K70.93%-941K146.68%1.68M
Earnings from equity interest net of tax
Net income 64.57%-534K59.96%-1.09M146.57%651K142.41%1.22M229.68%6.86M-31.04%-1.51M-126.91%-2.73M78.78%-1.4M89.81%-2.88M49.60%-5.29M
Net income continuous operations 64.57%-534K59.96%-1.09M146.57%651K142.41%1.22M229.68%6.86M-31.04%-1.51M-126.91%-2.73M78.78%-1.4M89.81%-2.88M49.60%-5.29M
Noncontrolling interests
Net income attributable to the company 64.57%-534K59.96%-1.09M146.57%651K142.41%1.22M229.68%6.86M-31.04%-1.51M-126.91%-2.73M78.78%-1.4M89.81%-2.88M49.60%-5.29M
Preferred stock dividends
Other under preferred stock dividend
Net income attributable to common stockholders 64.57%-534K59.96%-1.09M146.57%651K142.41%1.22M229.68%6.86M-31.04%-1.51M-126.91%-2.73M78.78%-1.4M89.81%-2.88M49.60%-5.29M
Diluted earnings per share 71.43%-0.0264.29%-0.05142.86%0.03140.00%0.06225.93%0.340.00%-0.07-126.42%-0.1479.41%-0.0791.94%-0.1557.14%-0.27
Basic earnings per share 71.43%-0.0264.29%-0.05142.86%0.03140.00%0.06225.93%0.340.00%-0.07-126.92%-0.1479.41%-0.0791.94%-0.1557.14%-0.27
Dividend per share
Accounting Standards US-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAP
Audit Opinions ------Unqualified Opinion--------Unqualified Opinion with Explanatory Notes--

FY: Financial Year. Refers to the 10-K file disclosed by the listed company to the SEC.

Q: Quarter. Refers to the 10-Q file disclosed by the listed company to the SEC. Q1, Q2, Q3, and Q4 are quarterly reports each with a span of 3 months; Q6 and Q9 are cumulative reports, with Q6 including 6 months and Q9 9 months.

Heat List
CA
Overall
Symbol
Latest Price
%Chg